Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.
Join now to get the NewsHeater.com pre-market morning brief 100% free
Welcome to the Market Globalist, a free online newspaper packed with exclusive content, news, articles and much more!
The site was born on May, 2nd, 2010 and while stays in the status of the newborn. But we hope that the “baby” will grow strong, moderately amusing, not impudent, sociable and not dull. And with it we are will helped, certainly, by you are our readers whom every day will become more and more.